PHAT PHATHOM PHARMACEUTICALS INC
FollowCOMMON STOCK (common), issuer CIK 1783183
Filings received so far for Q3 2026: 4 13F filers report a position in PHAT shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Narula Sanjeevofficer (Chief Financial & Bus. Officer) | 2026-10-06 | -13,485 F | $6.78 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 19,914 | $145K | 0.02% | 0 | 13F-HRTimeline |
| GAMMA Investing LLC | 505 | $3.69K | <0.01% | +105 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 396 | $2.89K | <0.01% | +54 | 13F-HRTimeline |
| ELEVATION WEALTH PARTNERS, LLC | 20 | $146 | <0.01% | 0 | 13F-HRTimeline |
Events
Narula Sanjeev disposed of 13,485 PHAT shares on 2026-10-06, Form 4 filed 2026-10-08. 0001193125-26-418114
Accepted , ingested